Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Composite and surrogate outcomes in randomised controlled trials.

Literature DB >> 17431231

Composite and surrogate outcomes in randomised controlled trials.

Nick Freemantle, Mel Calvert.

Abstract

Mesh：

Year: 2007 PMID： 17431231 PMCID： PMC1852018 DOI： 10.1136/bmj.39176.461227.80

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

6 in total

1. End-point interpretation in clinical trials: the case for discipline.

Authors: L A Moyé
Journal: Control Clin Trials Date: 1999-02

2. Composite outcomes in randomized trials: greater precision but with greater uncertainty?

Authors: Nick Freemantle; Melanie Calvert; John Wood; Joanne Eastaugh; Carl Griffin
Journal: JAMA Date: 2003-05-21 Impact factor: 56.272

Review 3. Validity of composite end points in clinical trials.

Authors: Victor M Montori; Gaietà Permanyer-Miralda; Ignacio Ferreira-González; Jason W Busse; Valeria Pacheco-Huergo; Dianne Bryant; Jordi Alonso; Elie A Akl; Antònia Domingo-Salvany; Edward Mills; Ping Wu; Holger J Schünemann; Roman Jaeschke; Gordon H Guyatt
Journal: BMJ Date: 2005-03-12

Review 4. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.

Authors: Ignacio Ferreira-González; Jason W Busse; Diane Heels-Ansdell; Victor M Montori; Elie A Akl; Dianne M Bryant; Pablo Alonso-Coello; Jordi Alonso; Andrew Worster; Suneel Upadhye; Roman Jaeschke; Holger J Schünemann; Gaietà Permanyer-Miralda; Valeria Pacheco-Huergo; Antònia Domingo-Salvany; Ping Wu; Edward J Mills; Gordon H Guyatt
Journal: BMJ Date: 2007-04-02

5. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

Authors: Steven E Kahn; Steven M Haffner; Mark A Heise; William H Herman; Rury R Holman; Nigel P Jones; Barbara G Kravitz; John M Lachin; M Colleen O'Neill; Bernard Zinman; Giancarlo Viberti
Journal: N Engl J Med Date: 2006-12-04 Impact factor: 91.245

6. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

Authors: H C Gerstein; S Yusuf; J Bosch; J Pogue; P Sheridan; N Dinccag; M Hanefeld; B Hoogwerf; M Laakso; V Mohan; J Shaw; B Zinman; R R Holman
Journal: Lancet Date: 2006-09-23 Impact factor: 79.321

6 in total

15 in total

1. Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19).

Authors: Sergio Amadori; Stefan Suciu; Dominik Selleslag; Roberto Stasi; Giuliana Alimena; Liliana Baila; Vittorio Rizzoli; Erika Borlenghi; Gianluca Gaidano; Domenico Magro; Giuseppe Torelli; Petra Muus; Adriano Venditti; Emma Cacciola; Francesco Lauria; Marco Vignetti; Theo de Witte
Journal: Br J Haematol Date: 2010-03-08 Impact factor: 6.998

Review 2. Do we learn the right things from clinical trials?

Authors: Silvio Garattini; Vittorio Bertele'
Journal: Eur J Clin Pharmacol Date: 2008-01-29 Impact factor: 2.953

Review 3. Biomarker development for axial spondyloarthritis.

Authors: Matthew A Brown; Zhixiu Li; Kim-Anh Lê Cao
Journal: Nat Rev Rheumatol Date: 2020-06-30 Impact factor: 20.543

4. What's new in trial design: propensity scores, equivalence, and non-inferiority.

Authors: Paul S Myles
Journal: J Extra Corpor Technol Date: 2009-12

5. Opportunities and challenges of clinical trials in cardiology using composite primary endpoints.

Authors: Geraldine Rauch; Bernhard Rauch; Svenja Schüler; Meinhard Kieser
Journal: World J Cardiol Date: 2015-01-26

Review 6. Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer?

Authors: Lothar R Pilz; Christian Manegold; Gerald Schmid-Bindert
Journal: Transl Lung Cancer Res Date: 2012-03